Drug Survival Associated with Effectiveness and Safety of Treatment with Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients with Psoriasis
Yiu, Z. Z. N., Becher, G., Kirby, B., Laws, P., Reynolds, N. J., Smith, C. H., Warren, R. B. & Griffiths, C. E. M., Oct 2022, In: JAMA dermatology. 158, 10, p. 1131-1141 11 p.
Research output: Contribution to journal › Article › peer-review